Michael H. Arenberg
Net Worth
Last updated:
What is Michael H. Arenberg net worth?
The estimated net worth of Mr. Michael H. Arenberg is at least $2,763,561 as of 12 Mar 2019. He owns shares worth $45,921 as insider and has received compensation worth at least $2,717,640 in DURECT Corporation.
What is the salary of Michael H. Arenberg?
Mr. Michael H. Arenberg salary is $452,940 per year as Chief Financial Officer & Sec. in DURECT Corporation.
How old is Michael H. Arenberg?
Mr. Michael H. Arenberg is 55 years old, born in 1970.
What stocks does Michael H. Arenberg currently own?
As insider, Mr. Michael H. Arenberg owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| DURECT Corporation (DRRX) | Chief Financial Officer & Sec. | 24,426 | $1.88 | $45,921 |
What does DURECT Corporation do?
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Santen Pharmaceutical Co., Ltd. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
Michael H. Arenberg insider trading
DURECT key executives
DURECT Corporation executives and other stock owners filed with the SEC:
- Dr. James E. Brown D.V.M. (68) Co-Founder, Chief Executive Officer, Pres & Director
- Dr. Norman L. Sussman (72) Chief Medical Officer
- Mr. Michael H. Arenberg (55) Chief Financial Officer & Sec.
- Ms. Judy R. Joice (68) Senior Vice President of Operations & Corporation Quality Assurance